Publications
59
Citations
1,258
Est. group size
~4
Recurring co-author estimate
Active years
14
Publishing since 2013
Fanfei Meng's research centers on developing nanoparticle-based delivery systems for cancer treatment, including combining chemotherapy with immune-boosting therapies (chemoimmunotherapy) tested in mouse models and a pilot study in dogs. Related work also explores how to deliver nucleic acid-based drugs (like RNA therapeutics) more efficiently into cells, which is relevant to treating cancer and other diseases. The work bridges materials science, drug delivery engineering, and preclinical cancer research.
Publication output has grown substantially over the last decade, rising from occasional single papers before 2020 to a sharp increase in recent years (2024-2026).
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Supplementary Fig. 3 from Nanoparticulate Immunoactive Complex for Local Chemoimmunotherapy: From Murine Models to Pilot Canine Study
2026
- Supplementary Table 1 from Nanoparticulate Immunoactive Complex for Local Chemoimmunotherapy: From Murine Models to Pilot Canine Study
2026
- Figure 1 from Nanoparticulate Immunoactive Complex for Local Chemoimmunotherapy: From Murine Models to Pilot Canine Study
2026
- Supplementary Fig. 4 from Nanoparticulate Immunoactive Complex for Local Chemoimmunotherapy: From Murine Models to Pilot Canine Study
2026
- Figure 2 from Nanoparticulate Immunoactive Complex for Local Chemoimmunotherapy: From Murine Models to Pilot Canine Study
2026
- Table 4 from Nanoparticulate Immunoactive Complex for Local Chemoimmunotherapy: From Murine Models to Pilot Canine Study
2026
- Figure 8 from Nanoparticulate Immunoactive Complex for Local Chemoimmunotherapy: From Murine Models to Pilot Canine Study
2026
- Supplementary Fig. 2 from Nanoparticulate Immunoactive Complex for Local Chemoimmunotherapy: From Murine Models to Pilot Canine Study
2026
- Data from Nanoparticulate Immunoactive Complex for Local Chemoimmunotherapy: From Murine Models to Pilot Canine Study
2026
- Figure 4 from Nanoparticulate Immunoactive Complex for Local Chemoimmunotherapy: From Murine Models to Pilot Canine Study
2026
- Figure 6 from Nanoparticulate Immunoactive Complex for Local Chemoimmunotherapy: From Murine Models to Pilot Canine Study
2026
- Table 2 from Nanoparticulate Immunoactive Complex for Local Chemoimmunotherapy: From Murine Models to Pilot Canine Study
2026
- Table 3 from Nanoparticulate Immunoactive Complex for Local Chemoimmunotherapy: From Murine Models to Pilot Canine Study
2026
- Figure 5 from Nanoparticulate Immunoactive Complex for Local Chemoimmunotherapy: From Murine Models to Pilot Canine Study
2026
- Figure 7 from Nanoparticulate Immunoactive Complex for Local Chemoimmunotherapy: From Murine Models to Pilot Canine Study
2026
- Journal of Controlled Release×4
- ACS Nano×3
- Biomaterials×2
- Nano Research×2
- Angewandte Chemie International Edition×2
- Marejka H. Shaevitz
Medicine · Purdue University West Lafayette
- Deborah W. Knapp
Medicine · Purdue University West Lafayette
- R. Timothy Bentley
Medicine · Purdue University West Lafayette
- Meaghan M. Broman
Medicine · Purdue University West Lafayette
- Christopher M. Fulkerson
Medicine · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile